We are beating back COVID-19. As of May 14, 2021, over 35% of the U.S. population has had both doses of an approved vaccine. The moving weekly average of cases continues downward; however, this is not the time to assume that treatment innovations can stop. We have seen firsthand how tough this virus can be on vulnerable populations and how diverse and complicated its effects are.